tailieunhanh - Báo cáo khoa học: Oligomerization is required for the activity of recombinant soluble LOX-1

LOX-1 is a scavenger receptor that functions as the primary receptor for oxidized low-density lipoprotein (OxLDL) in endothelial cells. The binding of OxLDL to LOX-1 is believed to lead to endothelial activation, dysfunc-tion, and injury, which constitute early atherogenic events. Because of its potential pathological role in atherosclerosis, LOX-1 has been proposed as a therapeutic target for the treatment of this disease. | ỊFEBS Journal Oligomerization is required for the activity of recombinant soluble LOX-1 XAMi c yao1 ya sri a c ya l ea l-t N 1 A H o Root1 yara1 l hptpmpnpp I am1 .Qtpnhpnp fXllanrl1 vve vau V alcllc kzdld UIU MUalll nuui JldUC I dll Ixl Icicl lienee Ldl II o Lcpildllc J I lai IU Jocelyn Sanford1 Angela Robdk1 Richard Zollner1 Zhijian Lu1 Mostdfd Ait-Zdhra1 Rita Agostinelli1 Lioudmila Tchistiakova1 Davinder Gill1 Douglas Harnish2 Janet Paulsen1 and Heather H. Shih1 1 Department of BiologicalTechnologies Wyeth Research Cambridge MA USA 2 Department of Metabolic Diseases Wyeth Research Cambridge MA USA Keywords Fc fusion protein LOX-1 receptor oligomerization recombinant protein scavenger receptor Correspondence H. H. Shih Department of Biological Technologies Wyeth Research 87 Cambridge Park Drive Cambridge MA 02140 USA Fax 1 617 665 8350 Tel 1 617 665 7473 E-mail hshih@ These authors contributed equally to this work Received 30 January 2009 revised 31 May 2009 accepted 1 July 2009 doi LOX-1 is a scavenger receptor that functions as the primary receptor for oxidized low-density lipoprotein OxLDL in endothelial cells. The binding of OxLDL to LOX-1 is believed to lead to endothelial activation dysfunction and injury which constitute early atherogenic events. Because of its potential pathological role in atherosclerosis LOX-1 has been proposed as a therapeutic target for the treatment of this disease. In order to antagonize the ligand-binding function of cell surface LOX-1 we generated a series of recombinant human LOX-1-crystallizable fragment Fc fusion proteins and subsequently characterized their biochemical properties and ligandbinding activities in vitro. Consistent with the notion that oligomerization of cell surface LOX-1 is required for high-avidity binding of ligands we found that LOX-1-Fc fusion protein containing four ligand-binding domains per Fc dimer but not the one containing two ligand-binding domains exhibited

crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.